1. Bian, Weihua, Jing, Xiaohong, Yang, Zhiyu, Sun, Yeying, Zhang, Chunxiang. 2020. Downregulation of LncRNA NORAD promotes Ox-LDL-induced vascular endothelial cell injury and atherosclerosis. In Aging, 12, 6385-6400. doi:10.18632/aging.103034. https://pubmed.ncbi.nlm.nih.gov/32267831/
2. Jia, Yunlong, Tian, Cong, Wang, Hongyan, Wang, Jiali, Liu, Lihua. 2021. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin. In Molecular cancer, 20, 162. doi:10.1186/s12943-021-01455-y. https://pubmed.ncbi.nlm.nih.gov/34893064/
3. Pérez-Navarro, Yussel, Salinas-Vera, Yarely M, López-Camarillo, Cesar, Figueroa-Angulo, Elisa Elvira, Alvarez-Sánchez, María Elizbeth. 2024. The role of long non-coding RNA NORAD in digestive system tumors. In Non-coding RNA research, 10, 55-62. doi:10.1016/j.ncrna.2024.09.002. https://pubmed.ncbi.nlm.nih.gov/39296642/
4. Soghli, Negin, Yousefi, Tooba, Abolghasemi, Maryam, Qujeq, Durdi. 2020. NORAD, a critical long non-coding RNA in human cancers. In Life sciences, 264, 118665. doi:10.1016/j.lfs.2020.118665. https://pubmed.ncbi.nlm.nih.gov/33127516/
5. Ventura, Andrea. 2016. NORAD: Defender of the Genome. In Trends in genetics : TIG, 32, 390-392. doi:10.1016/j.tig.2016.04.002. https://pubmed.ncbi.nlm.nih.gov/27157388/